The evolution of prenatal screening for Down syndrome continues with the introduction of nuchal translucency (NT) measurement _ along with PAPP-A, hCG, and dimeric inhibin-A _ in the first trimester. This combination of markers provides early consistent and reliable screening for Down syndrome and trisomy 18. This test is available for women who would rather not wait for conventional second trimester screening. 
Precise, expert ultrasonographers
Because the accuracy of the screening depends on the integrity of the ultrasound of fetal nuchal translucency measurements, sonographers with documented expertise in first trimester measurements of this type must conduct the NT measurements. Specialized training as well as ongoing image review are required as part of certification.
Reimbursement
Most insurers should cover First Trimester Screening to the extent that they cover prenatal ultrasound and serum screening procedures.
Patients are encouraged to check with their insurance carriers if in doubt.
